Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Market Cap	94.59B
Revenue (ttm)	87.31B
Net Income (ttm)	9.94B
Shares Out	44.08M
EPS (ttm)	225.41
PE Ratio	9.52
Forward PE	9.37
Dividend	46.00 (2.15%)
Ex-Dividend Date	Mar 28, 2025

Volume	49,000
Average Volume	69,480
Open	2,167.00
Previous Close	2,146.00
Day's Range	2,125.00 - 2,167.00
52-Week Range	1,921.00 - 2,505.00
Beta	0.07
RSI	36.63
Earnings Date	May 8, 2025

About Zeria Pharmaceutical

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers produ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 1,777
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4559

Financial Performance

In 2024, Zeria Pharmaceutical's revenue was 87.31 billion, an increase of 15.30% compared to the previous year's 75.73 billion. Earnings were 9.94 billion, an increase of 28.52%.